Drugs / CCR5mAb004
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00114699 | Apr 2005 → Apr 2006 | HIV infectious disease | Human Genome Sciences Inc. | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ccr5mab004 | “Ccr5mab004 (Human Monoclonal Igg4 Antibody To Ccr5)” NCT00114699 ↗ |
| Modality | Monoclonal antibody | “Human Monoclonal Igg4 Antibody To Ccr5” NCT00114699 ↗ |
| Route | Intravenous | “single intravenous (IV) infusion” NCT00114699 ↗ |
| Target | CCR5 | “Antibody To Ccr5” NCT00114699 ↗ |